- Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
- Papadakis KA. Targan SR. Current theories on the causes of inflammatory bowel disease Gastroenterol Clin North Am 1999;28:283-96.
- Bischoff SC. Wedemeyer J. Herrman A. Meier PN. Trautwein C. Cetin Y. et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13.
- Levi-Schaffer F. Mast cell/fibroblast interactions in health and disease. Chem Immunol 1995;61:161-85.
- Levi-Schaffer F. Weg VB. Mast cells, eosinophils and fibrosis. Clin Exp Allergy 1997;27 Suppl 1:64-70.
- Metcalfe DD, Baram D. Mekori YA. Mast cells. Physiol Rev 1997;77:1033-79.
- Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997;99:155-60.
- Eckes B, Kessler D. Aumailley M. Krieg t. Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis springer Semin Immunopathol 1999;21:415-29.
- Trojanowska M, Le Roy EC, Eckes B, Krieg t. pathogenesis of fibrosis: type I collagen and the skin. J Mol Med 1998;76:266-74.
- Regan MC. Flavin lBM. Fitzpatrick JM. O'Connel PR. Stricture formation in Crohn's disease. The role of intestinal fibroblasts. Ann Surg 2000;231:46-50.
- Bischoff SC, Lorentz A, Schwengbeg S, Weier G, Raab R, Manns MP. Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 1999;44:643-52.
- Babyatsky MW. Rossiter G. PodoIsky DK. Expression of transforming growth factors a and ß in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110:975-84.
- Raithel M, Matek M, baenkler HW, Jorde W, Hahn EG. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol 1995;108:127-33.
- Bischoff SC, Grabowsky J. Manns MP. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 1997;42:394-403.
- Ghosh S. Humphreys K, Papachrysostomou M, Ferguson A. Detection of insulin-like growth factor-I and transforming growth factor-beta in whole gut lavage fluid: a novel method of studying intestinal fibrosis. Eur J Gastroenterol Hepatol 1997;9:505-8.
- Morris GP. beck PL, Herridge MS, Depew WT, Szewezuk MR. Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
- Wasserman SI. Immunopharmacologic profile of nedocromil sodium. Allergy Proc 1995;16:67-71.
- Riley JF, West GB. Tissue mast cells: studies with a histamine liberator of low toxicity (compound 48/80). J. Pathol bacteriol 1955;69:269-82.
- Jaffery G. Coleman JW. Huntley J. Huntley J. Bell EB. Mast cell recovery following chronic treatment with compound 48/80. Int Arch Allergy Immunol 1994;105:274-80.
- Levi-Schaffer F, Riesel N, Soffer D, Abramsky O. Brenner T. Mast cell activity in experimental allergic encephalomyelitis. Mol Chem Neuropathol 1991;15:173-84.
- Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, et al. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am J Gastroenterol 2000;95:966-73.
- Nagler A. Pines M. Topical treatment of cutanceous graft versus host disease with halofuginone: a novel inhibitor of collagen type l synthesis. Transplantation 1999;68:1806-9.
- Dabev D, Struck H. Microliter determination of free hydroxyproline in blood serum, Biochem Med 1971;5:17-21.
- Berton A, Levi-Schaffer F, Emonard H, Garbuzenko E, Gillery P, Maquart FX, Activation of fibroblasts in collagen lattices by mast cell extract: a mode of fibrosis, Clin Exp Allergy 1999;30:485-92.
- Levi-Schaffer F. Garbuzenko E, Rubin A, Rubin A. Reich R, Pickholz D, et al. Human eosinophils regulate human lung and skin-derived fibroblast properties in vitro: a role for transforming growth factor ß(TGF-ß). Proc Natl Acad Sci USA 1999;96:9660-5.
- Bousvaros A, Zurakowski D, Fishman SJ, Keough K, Law T, Sun C, et al. Serum basic fibroblast growth factor in pediatric Crohn's disease Implication for wound healing. Dig Dis Sci 1997;42:378-86.
- Grace RH. Gent AE, Hellier Md. Comparative trial of sodium cromoglycate enemas with predinisolone enemas in the treatment of ulcerative colitis. Gut 1987;28:88-92.
- Craps LP. Key UM. Ketotifen: current views on its mechanisms of action and their therapeutic implications. Respiration 1984;45:411-21.
- Eliakim R, Karmeli F, Okon E. Rachmilewitz D. Ketotifen effectively prevents mucosal damage in experimental colitis. Gut 1992;33:1498-503.
- Eliakim R, Karmeli F, Okon E, Rachmilewitz D. Ketotifen ameliorates capsaicin-augmented acetic acid-induced colitis. Dig Dis Sci 1995;40:503-9.
- Araki Y, Andoh A, Fujiyama Y, Bamba T, Development of dextran sulphate sodium-induced experimental colitis is supressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 2000;119:264-9.
- Mekori YA, Baram D. Goldberg A, Hershkoviz R, Reshef T, Sredni D, Nedoeromil sodium inhibits T-cell function in vitro and in vivo. J Allergy Clin Immunol 1993;91:817-24.
- Befus AD, Bissonette EY. Modulation of mast cell function in the gastrointestinal tract. In: Immunopharmacology of the gastrointestinal system. New York: Academic Press; 1993. p.95-103.
- Levi-Schaffer F, Rubinchik E. Interleukin-2 modulation of mast cell hitamine release is affected by nedocromil sodium. J Allergy Clin Immuno 1993;91:185.
- Joseph M, Rainey DK. Basic research on nedocromil sodium. Rev Mal Respir 1992;9:R93-7.
- Hoenstein R, Admon D, Solomon A, Norris A, Moqbel R, Levi-Schaffer F, Interleukin-2 activates human peripheral blood eosinophils. Cellular Immunol 2001;210:116-24.
- Weber KT, Sun Y, Katwa LC. Local regulation of extracellular matrix structure. Herz 1995;20:81-8.
- Levi-Schaffer F, Rubinchick E. Activated mast cells are fibrogenic for 3T3 fibroblast. J Invest Dermatol 1995;104:999-1103.
- Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J. Ren S, et al. Human mast cells activate fibroblasts. Tryptase is a fibrogenic factor stimulating collagen messager ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997;158:2310-7.
- Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997;158:2310-7.
- Norrby K. Evidence of mast cell histamine being mitogenic intact tissue. Agents Actions 1985;16:287-90.
- Jordana M, Befus AD. Newhouse MT. Bienenstock J. Gauldie J. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 1988;43:552-8.
- Kupietzky A. Levi-Schaffer F. The role of mast cell-derived histamine in the closure of an in vitro would. Inflamm Res 1996;45:176-80.
- Gordon JR. Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc RI. Role for mast cell-derived transforming growth factor ßand tumor necrosis factor ?. J Exp Med 1994;180:2027-37.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 3